Abstract

Objectives clinically leery novel coronavirus ( COVID-19 ) lung pneumonia can be observed typically on computed imaging ( CT ) chest scans even in patients with a negative real-time polymerase chain reaction ( RT-PCR ) examination. The purpose of the study was to describe the CT imagination findings of five patients with negative RT-PCR results on initial and repeat test but a high radiological suspicion of COVID-19 pneumonia. Methods

Out of 19 clinically and/or radiologically diagnosed COVID-19 patients from our institution, five patients were selected for our study who had distinctive findings of COVID-19 on CT scan despite two negative RT-PCR results. Two district general hospital radiologists reviewed the chest computerized tomography images without prior cognition of the RT-PCR test results. Scans were analyzed for the density of opacification and the distribution of disease. Results Out of 19 patients, five ( 26 % ) had initial negative RT-PCR trial findings but cocksure CT breast features coherent with COVID-19. All patients had typical CT imaging findings of COVID-19. These included one patient with strictly ground-glass opacities ( GGO ) and four patients with interracial GGO and consolidation. The distinctive distribution of parenchymal interest was bilateral, later, and peripheral. Of the five patients with damaging RT-PCR and positive CT findings, the range of CT asperity score was 5 to 14. The medial score, seen in three patients, was a grudge of 5, which corresponded to mild disease. One affected role had a grudge of 8, corresponding to moderate disease, and one patient had severe disease with a score of 14. conclusion Lung parenchymal changes related to COVID-19 can be seen on breast CT intelligibly despite repeated RT-PCR minus results. Keywords:

novel coronavirus, covid-19, 2019-ncov, sars-cov-2, chest ct, rt-pcr

Introduction

The current novel coronavirus ( 2019-nCoV ) pandemic was first base identified in Wuhan, Hubei province, the Republic of China in December 2019 [ 1 – 4 ]. It was initially described as pneumonia of obscure origin but concisely subsequently, the virus was identified as belong to the coronavirus family and named novel coronavirus ( COVID-19 ). From China, it spread quickly across the ball, to be declared a pandemic by the World Health Organisation ( WHO ) on February 11, 2020 [ 5 ]. A thorax roentgenogram is the primary visualize modality for investigating COVID suspected patients. The use of chest of drawers computed imaging ( CT ) as an visualize modality for patients with suspect COVID-19 is not well-established. From our cohort of 19 patients with typical CT findings for COVID-19, five patients had two negative reversion transcriptase-polymerase chain reaction ( RT-PCR ) results. RT-PCR tests for diagnosing COVID-19 harbors false-negative findings for a variety of reasons : the floor of viral ribonucleic acidic ( RNA ) being below detectable limits, insufficient cellular material for signal detection, and improper extraction of nucleic acid from clinical samples. These variables may explain why some COVID-19 tests are negative in the presence of apparent clinical disease. In our report, we present the breast CT findings of five patients with COVID-19 pneumonia who had two consecutive, negative RT-PCR results. In this paper, we describe the clinical features and specific diagnostic visualize characteristics of COVID-19 for each patient .

Materials and methods

This was a retrospective study for which the necessity for patients ’ informed accept had been waived. Patient data were collated from a hospital information encrypted condom locate named Clinical Record Interactive Search ( CRIS ), movie archive and communication system ( PACS ), affected role web portal vein, patient dismissal summaries, and NHS Trust encrypted web sites. All data were anonymized and no affected role contact was made. inclusion criteria for the report 1 ) CRIS ( Clinical Record Interactive system = Radiology Information System ) and PACS searches were done from February 1 – May 24, 2020, for keywords “ COVID ”, “ CT Chest ”, “ HRCT ”, “ COVID pneumonia ”, “ COVID-19 ”, “ Novel Coronavirus ”, Coronavirus pneumonia ”, and “ ? COVID ”. 2 ) Patients aged 18 to 100 years with symptoms of suspect COVID-19, investigated by breast CT and RT-PCR, between 1st February 1 to May 24, 2020. 3 ) Patients with a high clinical or initial radiological misgiving of COVID-19, for example, fever, cough, shortness of hint ( SOB ), dependant on O2, and non-specific patchy shadowing on chest roentgenogram. 4 ) Incidental findings of COVID-19 on preoperative CT scan in otherwise asymptomatic patients. 5 ) Patients with RT-PCR and film array minus trial results. human body shows the survival criteria .An external file that holds a picture, illustration, etc.
Object name is cureus-0012-00000009942-i01.jpgOpen in a separate window excommunication criteria 1 ) Patients younger than 18 years or older than 100 years 2 ) Patients with incontrovertible RT-PCR on initial or duplicate examination 3 ) Patients with no radiological testify of COVID-19 4 ) Patients with probable bacterial or other viral pneumonia ( film range tests )

Having employed inclusion body and exclusion criteria through careful excerpt, five of the 19 patients ( 3 women, 2 men ; long time range 42-53, bastardly age 48, medial long time 51 ) who received a chest CT were enrolled for the study. fourteen patients were excluded from the discipline, as their initial and/or repeat RT-PCR results were plus. All patients undergo CT read of the chest on the lapp day that the initial RT-PCR test was performed. CT protocols Patients were scanned using either non-contrast high-resolution CT ( HRCT ), arterial phase chest CT, or CT pneumonic angiogram ( CTPA ). All images were obtained from a CT scanner ( GE Frontier, GE Healthcare, Chicago, IL ) with patients in the resistless side. The technical parameters for all examinations are summarized below : HRCT and CT CAP : 120 kilovolt, auto-modulated master of arts, 0.625 slice thickness, 512×512 matrix CTPA : 100 kilovolt, car modulated massachusetts, 0.625 cut thickness, 512×512 matrix prototype analysis Images were reviewed by two UK-certified adviser radiologists ( E.P. and U.M., with 25 and 5 years of know, respectively ). The chest computerized tomography images were reviewed individually by each radiologist on a picture archiving and communication arrangement ( PACS, Carestream Healthcare, Rochester, NY ). individual radiologists ’ results were collate and discrepancies were reviewed together to achieve a consensus decision regarding badness score and lesion characteristics. Chest CT images were evaluated on both mediastinal ( width 350 HU, level 40 HU ) and lung ( width 1500 HU, level -500 HU ) window settings. Two radiologists defined pneumonic lesions according to their location, density, condition, and margin. The placement of the lung lesions was recorded according to their lobar, axial, and anteroposterior distribution. The axile placement of a lesion was classified as cardinal ( inner two-third of the lung ) vs peripheral ( extinct one-third of the lung ) and anterior vanadium back tooth ( defined by a divide tune drawn horizontally through the center field of the breast ). The densities of the lesions were classified as saturated GGO, saturated consolidation, or blend. Lesion form was classified as amorphous, nodular, or cuneate. wound margins were classified as well-defined or ill-defined. The presence or absence of the following 18 extra findings was besides recorded : bronchial wall thicken, subpleural bands, vascular engorgement, aura sign, reverse halo sign, tree-in-bud, linear opacity, septal thicken, crazy paving, cavitation, cysts, pleural effusion, pleural thicken, pneumothorax, emphysema, mediastinal lymphadenopathy, subpleural spar, and air bronchograms. The huge majority of the lesions were patchy, with irregular, ill-defined margins. consequently, wound sizes were not assessed. rather, a semi-quantitative asperity score was employed for each lung lobe : score 0 ( 0 % affair ) ; score 1 ( > 0 – ≤25 % interest ) ; score 2 ( > 25 % – ≤50 % engagement ) ; score 3 ( > 50 % – ≤75 % affair ) ; score 4 ( > 75 % – 100 % participation ) ocular asperity scoring ( from 0 to 4 ) was employed for each of the five lobes, giving a final accumulative asperity score from 0 to 20 for each patient ( Table ) .

Table 1

Predominant densityn* (total 5 patients)Percentage (%)Pure ground glass-0Pure consolidation-0GGO + Consolidation (mixed)5100Laterality  Bilateral5100Unilateral -0Predominant shape  Amorphous480Rounded 120Patchy5100Pattern morphology and other associated findingsCrazy paving-0Mosaic pattern-0Tree-in-bud120Halo sign-0Reverse halo sign-0Pleural thickening 120Pleural effusion120Fibrosis-0Mediastinal lymphadenopathy120Subpleural fibrotic line360Subpleural sparing120Focal vascular engorgement240Bronchial wall thickening120Septal thickening360Air bronchograms-0Well-defined or ill-defined   Well-defined120Ill-defined360Both120Lobar involvement (number of case bases)   Right upper lobe 5 Right middle lobe5 Right lower lobe5 Left upper lobe4 Left lower lobe 5 Severity score (0-20)5 Mild (0 – 6) 3 Moderate (7-13)1 Severe (14-20)1 Lesion distribution   Central 1 Peripheral4 No predilection- Anterior- Posterior4 No predilection- Open in a separate window testing ground tests All patients had nasopharyngeal swab tests for RT-PCR, film array, neutrophils, lymphocytes, C-reactive protein ( CRP ), and D-dimer tests .

Discussion

Novel coronavirus COVID-19 is a new highly contagious viral disease, which has affected the wholly globe. Diagnosis depends on the three cardinal number clinical findings of fever, cough, and shortness of breath. The RT-PCR trial has been regarded as a gold standard for the diagnosis of COVID-19 despite concerns regarding specificity and sensitivity. The test is time-consuming, and the handiness of test kits has been a limiting factor with see to monitoring the dispersed of disease. The chest computerized tomography manifestations of COVID-19 are being established but, to date, fiddling is known about the disease course and treatment. x ray is considered the first-line radiological creature for the diagnosis of COVID-19 ; however, CT is superscript in disease recognition and follow-up. A radiological examen can be carried out well in advance of the RT-PCR trial results and can, consequently, provide a function for patient triaging and surveillance. early recognition of the lung expression of the disease can besides help initiate early supportive discussion and possibly prevent patients requiring intensive concern where the disease outcomes are worse. The review of these five cases has highlighted typical CT findings that may assist in the early signal detection of suspected cases and may help bode and prevent complications such as acute respiratory syndrome. previous CT studies have shown that our cohort had distinctive features of COVID-19 on CT : a bilateral, multifocal, peripheral, lower partition, and buttocks lung involvement [ 4, 6 – 14 ]. We observed tree-in-bud [ 15 ] and mediastinal lymphadenopathy [ 16 ] in severe COVID-19 infection, which has not been frequently reported in the english literature. Crazy pavement was not seen in our cohort, which can be seen in the late phase of the disease. Limitations There are several limitations to the report. The retrospective design and belittled cohort are the obvious limitations. Another limit is the miss of resources, which restricted the number of repeat RT-PCR tests to not more than two. Out of our five patients, only three received two RT-PCR tests. Follow-up CT was not made, with the exception of a 51-year-old preoperative affected role ( Patient 5 ) .

Conclusions

CT scanning following chest x-ray plays an important function in detecting COVID-19 lung manifestations prior to the RT-PCT test results. COVID-19 can be diagnosed by CT anterior to the RT-PCR trial resultant role, and RT-PCR test electronegativity should not exclude the diagnosis of this disease. In the context of the current pandemic, in patients with clinical symptoms or a history of exposure, CT features of viral pneumonia should be regarded as strongly leery for COVID-19 pneumonia, despite negative RT-PCR test results. We recommend that in these cases, patients should be managed with allow infection control measures and RT-PCR dab examination should be repeated .

Notes

The subject published in Cureus is the resultant role of clinical experience and/or inquiry by independent individuals or organizations. Cureus is not creditworthy for the scientific accuracy or dependability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. additionally, articles published within Cureus should not be deemed a desirable ersatz for the advice of a modify health worry professional. Do not disregard or avoid professional medical advice due to content published within Cureus .

The authors have declared that no competing interests exist .

homo Ethics

accept was obtained by all participants in this study. National Health Service ( NHS ) Health Research Authority ( HRA ) UK issued approval IRAS No : 282408. National Health Service ( NHS ) Health Research Authority ( HRA ) UK approval was obtained and patient accept was waived. The datum for this study is derived from a separate parent unpublished study, which has been approved by the NHS Health Research Authority ( Study title : A feasibility report to inform further research into the role of radioscopy tests in the management and diagnosis of Novel 2019 Coronavirus ( 2019-nCoV, individual retirement account No : 282408, approval date : 06.05.2020 )

animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue .